Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to $1.7 million.

  • cbdMD's Gains from Investment Securities changed N/A to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 397261.46%. This contributed to the annual value of $599521.0 for FY2025, which is 7317.34% up from last year.
  • As of Q3 2025, cbdMD's Gains from Investment Securities stood at $1.7 million.
  • Over the past 5 years, cbdMD's Gains from Investment Securities peaked at $8.9 million during Q1 2021, and registered a low of -$6.9 million during Q2 2021.
  • Over the past 5 years, cbdMD's median Gains from Investment Securities value was -$48000.0 (recorded in 2023), while the average stood at -$69877.7.
  • As far as peak fluctuations go, cbdMD's Gains from Investment Securities crashed by 1473274.23% in 2021, and later soared by 176970.41% in 2024.
  • cbdMD's Gains from Investment Securities (Quarter) stood at $660417.0 in 2021, then tumbled by 109.24% to -$61000.0 in 2022, then dropped by 14.35% to -$69752.0 in 2023, then surged by 1769.7% to $1.2 million in 2024, then skyrocketed by 47.99% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.2 million for Q4 2024, and -$4828.0 during Q1 2024.